The following press releases highlight recent developments in key programs, events and research activities at Banner Alzheimer's Institute. If you are a memeber of the media and would like more information for a story use the following contacts:
- To reach a member of our media team weekdays from 8 a.m. - 5 p.m. email email@example.com
- After hours, call our on-call media line (after 5 pm, weekends, holidays): (602) 492-4770
- NIH Renews Funding of Banner Alzheimer's
Institute and Mayo Clinic Decades-Long Longitudinal Study of
Earliest Alzheimer's Disease Changes
Phoenix (August 6, 2014) - The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer's Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer's disease at older ages. The award, an estimated $8.3 million over the next five years, continues NIH's long-term support of the investigation.
Alzheimer's Institute Announces Partnership with Novartis in New
Study of Alzheimer's Prevention Treatments
Copenhagen, Denmark (July 15, 2014) -Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
imaging differences in infants at genetic risk for
PROVIDENCE, R.I. (Brown University, Nov. 5, 2013) - Researchers from Brown University and Banner Alzheimer's Institute have found that infants who carry a gene associated with increased risk for Alzheimer's disease tend to have differences in brain development compared to children without the gene. The study, published in JAMA Neurology, demonstrates some of the earliest developmental differences associated with a gene variant called APOE ε4, a common genotype and a known risk factor for late-onset Alzheimer's.
NIH Awards Grant to Banner Alzheimer's Institute for Major Study Evaluating Prevention Treatments for Alzheimer's Disease in At-Risk Older Adults
Phoenix, AZ (Sept. 18, 2013) - In collaboration with the National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI) announces a major prevention trial to evaluate a treatment in cognitively healthy older adults at the highest known genetic risk for developing Alzheimer's disease at older ages. An NIH grant, expected to total $33.2 million, will support this research.
Phoenix, AZ (Sept. 18, 2013) - Recognizing the need to accelerate research to prevent Alzheimer's disease and engage consumers, Banner Alzheimer's Institute (BAI) announced a major multi-corporation partnership today. The Global CEO Initiative on Alzheimer's disease (CEOi) and many of its member companies including: Bank of America, GE Healthcare, Janssen Research and Development, LLC., and Merck will partner together to highlight the need for greater research progress, a key emphasis of World Alzheimer's Day this Saturday.
Banner Alzheimer's Institute to open $16.3 million Imaging Center
PHOENIX, Ariz. (Feb. 5, 2013) - The opening of a $16.3 million state-of-the-art Imaging Center further cements the internationally-recognized work occurring at Banner Alzheimer's Institute (BAI) and advances statewide collaboration in Alzheimer's disease and other neuroscientific, cardiology and oncology research.
Banner Alzheimer's Institute is first research center in U.S. to participate in study using 'brain pacemaker' for Alzheimer's
PHOENIX, Ariz. (August 8, 2012) - Banner Alzheimer's Institute (BAI) is the first study site in the United States to participate in a cutting edge clinical trial utilizing deep brain stimulation (DBS) as a possible way to stave off the progression of Alzheimer's disease.
Alzheimer's Foundation launches $40 million campaign to advance
research and care
PHOENIX, Ariz. (June 6, 2012) - Banner Alzheimer's Foundation, the philanthropic resource for Banner Alzheimer's Institute, announces a $40 million campaign to advance some of the most challenging yet promising research to stop Alzheimer's disease.The BAI Breakthrough will support cutting-edge studies aimed at treating and preventing the disease, state-of-the-art brain imaging and an unparalleled model of patient and family care.
Alzheimer's disease prevention trial announced
PHOENIX, Ariz. (May 15, 2012) - In collaboration with the National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announce the first-ever prevention trial in cognitively healthy individuals who are destined to develop Alzheimer's disease because of their genetic history. This groundbreaking study-the first to investigate whether an anti-amyloid treatment can stave off the disease-will span two countries and help launch a new era of prevention research in the urgent fight against Alzheimer's.
Imaging Procedure Can Identify Biomarker Associated With Alzheimer
PHOENIX, Ariz. (Jan.19, 2011) - Preliminary research suggests that use of a type of molecular imaging procedure may have the ability to detect the presence of beta-amyloid in the brains of individuals during life, a biomarker that is identified during autopsy to confirm a diagnosis of Alzheimer disease, according to a study in the Jan.19 issue of Journal of the American Medical Association (JAMA).
Dr. Reiman named Rock Star of Science
PHOENIX - (Nov. 17, 2010) --Eric M. Reiman, MD, executive director of the Banner Alzheimer's Institute, has been recognized as a 2010 Rock Star of Science™, joining a select group of scientific leaders and Rock Stars in a campaign to celebrate biomedical research.
Banner Alzheimer's Institute awarded three grants
PHOENIX (June 14, 2010) - Banner Alzheimer's Institute has been awarded three grants totaling $7.1 million to advance Alzheimer's disease care and research initiatives.
Two Institutions get $21.5 million for Research Space
PHOENIX (May 17, 2010) Banner Alzheimer's Institute is one of two institutions awarded a combined $21.5 million in Federal stimulus grants to add or renovate research space.
Pampering the Caregiver Event
PHOENIX (May 3, 2010) -- The second annual "Pampering the Caregiver" event, sponsored by Banner Alzheimer's Institute, drew about a dozen grateful women who spend a lot of their time caring for a loved one with Alzheimer's disease.
Brain imaging study suggests genetic risk for Alzheimers in
PHOENIX, Ariz. (April 13, 2010) - A brain-imaging study published today in the Archives of Neurology suggests that major genetic risk factor for Alzheimer's disease in the Anglo population is also a risk factor for the disease in Latinos.
'Shopping to Remember' luncheon raises $13,000 for Banner
PHOENIX, Ariz. (April 13, 2010) - The Women's Council of the Banner Alzheimer's Institute (BAI), a dedicated group of community volunteers committed to raising funds and awareness on behalf of the nonprofit Banner Alzheimer's Foundation, hosted the fashion-inspired fundraising event Shopping to Remember generating $13,000 in support of programs and services for Alzheimer's disease patients and their families.
BAI receives caregiving award
PHOENIX (March 31, 2010) - The Banner Alzheimer's Institute was recently awarded the Rosalinde Gilbert Innovations in Alzheimer's Disease Caregiving Legacy Award for Diversity.
Retired Supreme Court Justice Sandra Day O'Connor joins Banner
Alzheimer's Foundation Board of Directors as Honorary
PHOENIX, Ariz. (Feb. 16, 2010) - The Board of Directors of the Banner Alzheimer's Foundation, the philanthropic resource for Banner Alzheimer's Institute, part of Phoenix-based nonprofit Banner Health, welcomes retired Supreme Court Justice Sandra Day O'Connor as an honorary member. A vocal supporter of the need to speed up Alzheimer's research efforts, O'Connor has been motivated by a personal tie to the devastating disease.
Free Alzheimer's workshop offered
PHOENIX, Ariz. (Jan.18, 2010) -Alzheimer's experts and specialists invite the general public to participate in a Feb. 12 workshop aimed at educating them with the latest information about Alzheimer's disease, current treatment and clinical research.
Banner Alzheimers Institute offers free memory screening
PHOENIX, Ariz. (Nov. 25, 2009) - Memory loss can affect anyone. Often, losing the car keys or not being able to recall the name of a familiar face can be attributed to simple foregetfulness. But sometimes, memory impairment can be a warning sign of a serious health problem.
Banner Sun Health join ground breaking study
SUN CITY, Ariz. (Oct. 2, 2009) -- Sun Health Research Institute and Banner Alzheimer's Institute today announced that they have been selected as national Phase III sites involved in a ground-breaking medical imaging study to detect Alzheimer's disease in its earliest stages.
Banner Alzheimer's Institute, Banner Sun Health Research Institute
begin clinical trial
SUN CITY, Ariz. (Sept. 1, 2009) Banner Sun Health Research Institute and Banner Alzheimer's Institute are conducting a study where immune globulin administered intravenously (IGIV) will be evaluated alongside standard-of-care medications for Alzheimer's disease.
Brain Imaging Study Suggests High Cholesterol may Increase Risk of
PHOENIX (Aug. 24, 2009) - A brain-imaging study published in the online edition of the journal NeuroImage suggests that higher cholesterol levels in a person's 50s and 60s may lead to brain changes associated with increased risk of developing Alzheimer's disease when they get older.
Arts Engagement Program looking for new members
PHOENIX (May 27, 2009) - The Arts Engagement Program is now enrolling community members in the early to moderate stages of the disease and their care partners for two free summer sessions.
Banner Alzheimer's Institute and AstraZeneca expand Alzheimer's
PHOENIX, Ariz. WILMINGTON, Del.(May 20, 2009) - The Banner Alzheimer's Institute and AstraZeneca (NYSE: AZN) today announced that they have signed a new collaboration agreement to validate and further develop [18F]-AZD4694 as a diagnostic tool for Alzheimer's patients.
Arizona Alzheimer's Consortium meeting
GLENDALE, Ariz. (April 6, 2009) -- Banner Alzheimer's Institute, Sun Health Research Institute and partners will host the 2009 Arizona Alzheimer's Consortium Annual Conference on Friday, May 29, from 8 a.m. to 5 p.m. at Renaissance Glendale Hotel & Spa, 9495 W. Coyotes Blvd. in Glendale.
Banner Alzheimer's Institute to provide free memory
SURPRISE, Ariz. (March 15, 2009) - Memory loss can affect anyone. Often, the aggravation of losing the car keys or the inability to recall the name of a familiar face can be attributed to a "senior moment," the inability to instantly recall something familiar. But sometimes, memory impairment can be a warning sign of a serious health problem.
Alzheimer's Institute offers caregiver workshops
PHOENIX (Jan. 13, 2009) - Caregiving for a loved one with Alzheimer's or related dementia can be overwhelming. That's why Banner Alzheimer's Institute has created a two-day workshop to help caregivers be more effective and resourceful in their day-to-day roles.
Alzheimer's Institute offers caregiver seminar
PHOENIX (Jan. 13, 2009) - As a caregiver of someone with a memory disorder do you need help? Attend the COMPASS (Caregivers of Memory-impaired Persons Acquiring Successful Strategies) class and learn how to begin to successfully navigate caregiving. This 90-minute program offered by Banner Alzheimer's Institute is free of charge and includes instruction and handout materials.
"Abby" to share Alzheimer's experience at Phoenix event
PHOENIX (Nov. 1, 2008) When Jeanne Phillips discusses the disease that stole her mother's memory and ability to write the Dear Abby advice column, she sees what she describes affectionately as a sea of bobblehead dolls.
Banner Alzheimer's Institute and Sun Health enrolling patients in
PHOENIX and SUN CITY, ARIZ. (June 9, 2008) - Banner Alzheimer's Institute and Sun Health Research Institute today announced that they are actively enrolling patients in a new study of the investigational drug Dimebon™ for the treatment of Alzheimer's disease. The study will evaluate the safety and efficacy of Dimebon in patients with Alzheimer's disease taken in combination with Aricept® (donepezil HCI tablets), an FDA-approved Alzheimer's treatment.
NIA awards Arizona researchers with $6.6 million grant to continue
groundbreaking brain imaging study
PHOENIX (April 21, 2008) - The National Institute on Aging has awarded a team of Arizona researchers with a five-year, $6.6 million grant to continue a landmark brain imaging study exploring the cognitive decline of healthy people at varying degrees of genetic risk for Alzheimer's disease.
Give priority to fighting Alzheimer's
PHOENIX (Feb. 23, 2008) -- Former House Speaker Newt Gingrich and former Sen. Bob Kerrey recently established a non-partisan Alzheimer's Study Group, consisting of national leaders, to increase public awareness about Alzheimer's disease and develop a strategic plan to address it in the most comprehensive way. A bold plan is critical if we are to find a way to prevent this disease.